Rakhi Harne

Clinical Post-Doctoral Research Fellow | Development Biologist | Immunology | Vaccine development (SARS-CoV-2/Tuberculosis) | Food enthusiast

Role
Post-doctoral Research Fellow at Seattle Children's
Location
Seattle, WA, US
LinkedIn followers
500 followers
Research & DevelopmentView LinkedIn profile

About Rakhi Harne

Seeking to drive translational growth in immunology and infectious diseases with a…

Experience

  1. Post-doctoral Research Fellow

    Seattle Children's

    Nov 2021 — Present · Seattle, WA, US

    Research topic – (a) Qualification of total IgG Endpoint Titer for Respiratory Syncytial Virus (RSV) Fusion protein.(b) Evaluating vaccine-mediated cellular immunogenicity of M72 antigen paired with clinical adjuvants against M.tb in male and female mouse models of tuberculosis (TB). • Significantly contribute to preclinical projects evaluating vaccine efficacy by multi-color flow cytometry in M.tb and nontuberculous mycobacteria (NTM) mouse models. • Responsible for performing multicolor (18/19 and 12/13 color panels) flow cytometry preclinical experiments, analyzing flow data evaluating innate and adaptive cell markers, cytokines, immune responses, summarize results and write reports for NIH. • Provide training to teammates in all steps of flow cytometry experiments in lab and data analysis. Oversee technical staff, coordinate experiments and guide on data analysis. • Contribute to writing and review of manuscripts and Standard Operating Procedures (SOPs). • Responsible for presenting scientific work internally and externally.• Assess immunological endpoints and candidate vaccine efficacy against a range of pathogens M.tb, NTM, SARS-CoV2 and RSV. • Manage clinical and preclinical projects, order reagents and work in highly collaborative team. • Designed and lead qualification assays by ELISA measuring precision, linearity, and specificity of total IgG Endpoint Titer against RSV Fusion proteins strain A and B. • Clinical trials: 21-0012 (Ph1 SARS-CoV-2), (Ph1 SARS-CoV-2), (Ph1 SARS-CoV-2), CyanVac BA.5 Phase 1, DMID MOMI-VAX, HDT Bio. • PreClinical: IMPAcTB contract, R61 and C17 grant. • Experience working in BSL3 containment facility.

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Rakhi Harne — Post-doctoral Research Fellow at Seattle Children's in Seattle, WA, US | Unifers